In the classic 'two-signal' model for B cell activation, signal 1 through the antigen receptor plus signal 2 through lymphokine receptors and CD40 leads to proliferation, but signal 1 alone leads to tolerance or anergy. In a protocol designed to deliver signal 1 in vitro with anti-δ without signal 2, purified small dense B cells from untreated mice exposed to any of three monoclonal anti-δ antibodies or to polyclonal anti-δ in vitro showed modest S phase entry at 50 µg/ml. In contrast, at low doses (0.1-0.5 µg/ml) of anti-δ, there was no cell cycle entry at 64 h, but apoptosis was accelerated at 16 h. Polyclonal anti-µ and three monoclonal anti-µs did not show this early apoptosis induction. Anti-CD40 and IL-4 inhibited apoptosis in B cells treated with 0.5 µg/ml anti-δ and increased S phase entry at 10 µg/ml anti-δ. Low-dose anti-δ (but not anti-µ) induced increased B7-2 and class II MHC expression on a subset of B cells, many of which were in apoptosis. Larger transient increases in c-Myc and Egr-1 expression were seen with low-dose anti-δ than with anti-µ, followed by an abrupt fall below baseline, a sequence previously linked to apoptosis. There was no change in Bcl-2, Bcl-x L or Bax. These data suggest a functional difference between δ and µ crosslinking on resting spleen B cells. A BCR stimulus sufficient for early activation events, but insufficient for full G 1 entry, may lead to apoptosis.
Introduction
In 1968, Bretcher and Cohn described their 'two-signal' model either anti-δ or anti-µ with apoptosis, whereas mature spleen B cells (which express up to 1 log more sIgD than sIgM) (9) of B cell activation, wherein antigen provides an initiation signal through the BCR (signal 1), and T h cells provide respond to these same concentrations of anti-δ or anti-µ with [ 3 H]thymidine incorporation (10). These newer data appear a progression signal (signal 2) via CD40 and lymphokine receptors (1) . The currently favored concept is that if a mature more convincing than older arguments suggesting that IgD may promote immunity over tolerance (11, 12) . B cell receives signal 1 without signal 2, anergy or apoptosis occurs, resulting in immunologic tolerance. Sensitivity to this
To study B cell activation and tolerance in vivo, Finkelman et al. injected mice with monoclonal anti-δ antibodies (13,14), mode of tolerance induction is greatest in neonatal B cells (2) and the centrocyte B cells of germinal centers (3) (4) (5) .
more recently using a protocol devised to block T cell help, FcγRII receptor engagement and the generation of new Mystery still surrounds the question of why mature naive B cells express sIgD as well as sIgM. Detailed examination of immature B cells from the bone marrow (15) . This treatment resulted in the up-regulation of MHC class II on B cells, sIg-initiated signal transduction has failed to reveal important differences between sIgD and sIgM (6, 7) . Furthermore, mice indicating activation (signal 1), but between day 3 and day 10 most of the B cells disappeared from lymphoid organs transgenic for either sIgD anti-hen egg lysozyme (HEL) or sIgM anti-HEL both contain B cells with the ability to respond (15) . Can apoptosis be the fate of mature B cells which receive signal 1 without signal 2, just as it appears to be the with activation or tolerance at the appropriate developmental stage (8) . Newly developed IgD ϩ IgM ϩ B cells 14 days after fate of immature B cells encountering self-antigens at a time when no T help is available? irradiation respond to high concentrations (25-50 µg/ml) of Annexin V-binding buffer (10 mM HEPES, pH 7.4, 140 mM finding no difference (data not shown). IL-4 reduced the in vitro apoptosis rate of B cells treated with 0.5 µg/ml anti-δ NaCl, 2.5 mM CaCl 2 ) at 4°C for 15 min. Cells were then suspended in a larger volume of binding buffer and analyzed Hδ a /1 to the rate seen in medium alone at 16 h (Table 1) . By 64 h this protection was lost (not shown). Anti-CD40, especially on the Epics 753 (Coulter) using a 488 nm argon laser excitatory band, 525 and 670 nm band-pass filters, and a in combination with IL-4, also inhibited anti-δ-induced apoptosis and caused cell cycle entry by 64 h (Table 1) . DM570 dichroic mirror.
Since we used whole anti-δ, the possibility of Fc receptor Western blots interaction must be considered. However, anti-FcγRII antibody 2.4G2 failed to block apoptosis acceleration by 0.1 µg/ml Cell (16ϫ10 6 /sample) were cultured as described (24) , har-Hδ a /1 (Fig. 1A and B) . The generalizability of our results to vested, washed twice in PBS and lysed in lysis buffer (1.2% other anti-δ antibodies was tested in the experiment shown NP-40, 150 mM NaCl, 25 mM HEPES, 5 mM NaF, 0.5% in Fig. 2 . Monoclonal HBδ7 and polyclonal goat anti-mousesodium deoxycholate supplemented with 1 mM PMSF, 10 mM δ both accelerated apoptosis like Hδ a /1 at 16 h ( Fig. 2A) and Na 3 VO 4 , 4.4 mg/ml β glycerophosphate, 10 mM sodium drove B cells into cycle by 64 h (Fig. 2B) . Antibody 11-26, pyrophosphate, 5 µg/ml each of antipain, aprotinin, leupeptin which cross-links poorly (15) , was much less effective at and trypsin inhibitor, 0.5 µg/ml pepstatin, 7.5 µg/ml bestatin, induction of both apoptosis and cell cycle entry. Apoptosis and 4 µg/ml phosphoramidon; Boehringer-Mannheim). After induction required a 10-fold higher concentration of 11-26 30 min on ice, the lysates were centrifuged 15 min at 12,000 than of other anti-δs. In contrast, anti-µ antibody did not show g, 4°C. The supernatants were transferred to new tubes and the early apoptosis-accelerating effect of anti-δ. B.7.6 anti-µ, stored at -20°C. Protein was quantitated using the BioRad frequently used for its superior stimulatory properties, showed assay. Aliquots of 40 µg protein per lane were loaded on 10, only a small increase in apoptosis at 0.1-1 µg/ml, both at 16 12 or 15% Tris-glycine gels and electrophoresed under and 64 h (Fig. 3) . Two less stimulatory monoclonal anti-µs, denaturing conditions. The proteins were electroblotted onto DS-1 and 331, showed even less increase in apoptosis Immobilon P membranes (Millipore, Bedford, MA). Mem- (Fig. 4) . Polyclonal anti-µ showed a small increase similar to branes were blocked for 2 h in 5% non-fat milk in TBS ϩ that of B.7.6 ( Fig. 5) . As with anti-δ, G 1 entry with B.7.6 or 0.5% Tween 20 (24) . The blots were incubated in TBS with polyclonal anti-µ required at least 10 µg/ml (Figs 1 and 3 ). 0.5% Tween containing the following rabbit IgG primary A useful way to contrast the anti-δ and anti-µ results is to antibodies: anti-Egr-1, anti-Bcl-x S/L , anti-c-Jun (Santa Cruz consider the difference in percent of apoptotic cells between Biotechnology, Santa Cruz, CA); anti-Bcl-2 (Calbiochem, San exposure to medium alone for 16 h and exposure to Diego, CA); and anti-c-Myc (Upstate Biotechnology, Lake 0.5-1 µg/ml antibody. For anti-δ Hδ a /1, this difference was Placid, NY). Blots were also probed with rat IgM anti-Bax 32% in Fig. 1 , whereas in Fig. 2 it was 34% for Hδ a /1, 37% (PharMingen). Secondary antibodies used were donkey antifor HBδ7, 32% for polyclonal anti-δ (all of which induced rabbit IgG-horseradish peroxidase (Amersham, Arlington substantial G 1 entry at 50 µg/ml) and 27% for 11-26 (which Heights, IL) and goat anti-rat IgM-horseradish peroxidase did not induce G 1 entry). In contrast, for the anti-µs this (Cappel, Durham, NC). Blots were developed with ECL difference was 11% for B.7.6 ( Fig. 3) , 15% for DS, 11% for reagents (Amersham) and exposed to film. 331 (Fig. 4) and 9% for polyclonal anti-µ (Fig. 5) . After 64 h exposure to 10-50 µg/ml of either anti-δ or anti-µ the percentResults age of apoptotic cells was often below the level observed in medium alone (Figs 1 and 3-6) whether substantial cell cycle Anti-δ is more effective than anti-µ at accelerating apoptosis entry was evident (Figs 1, 3, 5 and 6) or not (Fig. 4) .
in B cells at low concentrations in vitro
Seeking an alternative assay for early apoptosis, we performed dose-response curves with B.7.6 and polyclonal In short-term cultures of purified small dense spleen B cells we used AO staining (23) in order to derive the percent of anti-µ using MC540 to detect the loss of membrane phospholipid asymmetry at 16 h (25, 26). The results resembled the apoptotic cells as well as all the phases of the cell cycle from the same histograms. At concentrations 10-to 100-fold too AO data of Figs 3-5: 39-41% MC540 ϩ cells at 0-0.01 µg/ml, rising only to 48-50% at 1 µg/ml. In one 16 h experiment, we low for cell cycle entry, anti-δ induced more apoptosis in vitro than anti-µ (Figs 1-5 ). For example, at 0.1-1 µg/ml anti-δ observed 3% B cell apoptosis by AO in fresh cells, 29% in medium, 47% in 0.1 µg/ml anti-δ (Hδ a /1) and 48% in Hδ a /1, accelerated apoptosis occurred at the expense of the G 0 population at 16 h (Fig. 1A) . No entry from G 0 into G 1 was 0.1 µg/ml anti-δ plus 0.1 µg/ml anti-µ (B.7.6), indicating that anti-µ did not interfere with the apoptosis-inducing activity of observed at 64 h at anti-δ concentrations of ഛ10 µg/ml (Fig. 1B) . By 64 h, at 10-100 µg/ml of Hδ a /1, about half the anti-δ. Three experiments were performed to verify that the cells were in G 1 or S phase and the percent of apoptotic cells was less than that seen with 0-1 µg/ml. These results were observed apoptosis progressed to loss of viable cells. In the first, erythrosin B was used as an indicator for cells with obtained with resting B cells under conditions of extreme T cell depletion; however, to eliminate the possibility that the damaged plasma membranes after duplicate samples of 2ϫ10 6 cells were cultured for 16 h with 0.05, 0.1, 0.5 or effect of high-dose anti-δ on B cell cycle entry required another cell, in one experiment we compared the Hδ a /1 dose-1 µg/ml HδB7 anti-δ antibody (the apoptosis inducing range in Fig. 2 ), 25 µg/ml lipopolysaccharide or medium. Erythrosin response curves (0.1-50 µg/ml) of sort-purified B220 ϩ cells to sorted, recombined cells and unsorted cells, measuring B -cell recoveries in the samples in medium alone were 770 and 730ϫ10 3 , and in lipopolysaccharide 820 and 770ϫ10 3 cell cycle entry at 64 h, and percent apoptotic B220 ϩ cells, (16 h is too early for proliferation). Each of these counts was (28) . Figure 6 compares the dose-response curves for the plate-bound and soluble forms of Hδ a /1 within the same Ͼ2 SD higher than the mean of 485ϫ10 3 Ϯ 111 (SD) seen in the eight anti-δ cultures. The second and third contrasted cell experiment, and the result was entirely consistent with the data of Hasbold and Klaus. At both 16 and 64 h, plates recoveries with 0.5 µg/ml anti-δ or anti-µ (Table 2) , using two alternative viability measures, MC540 at 20 h (which stains incubated with 50 µg/ml Hδ a /1 stimulated increased apoptosis, with no progression into cycle; by 64 h, 10 µg/ml apoptotic and membrane-permeable cells) in experiment 1 and erythrosin B at 40 h (which stains only membranewas also effective. However, this effect was duplicated by about 1/200 as much anti-δ in solution, which did stimulate permeable cells) in experiment 2. In both these experiments viable cell recovery was less with the anti-δ antibodies than cell cycle entry at 10-50 µg/ml, as in Fig. 1 . Insight into the mechanism of the apoptosis-accelerating with anti-µ antibodies and greater without any antibodies. However, total cell recovery was not consistently different.
effect of anti-δ was sought by Western blot analysis of selected cellular oncogenes and Bcl-2 family members in B cells The discovery by Hasbold and Klaus that hyper-crosslinking of surface Ig leads to apoptosis (27) was prompted treated with a dose (0.2 µg/ml) of anti-δ sufficient to cause apoptosis but not cell cycle entry (Fig. 1 ) or a matching dose by a previous demonstration that plates incubated with 50-100 µg/ml anti-δ and anti-µ caused apoptosis, whereas soluble of anti-µ, using a stimulating anti-CD40 antibody as a positive control. Neither anti-δ nor anti-µ altered levels of Bcl-2, Bclantibody in the same concentration range led to proliferation x L or Bax (Fig. 7) . Anti-δ Hδ a /1 induced an early burst of Egrprotective (29) , induced a more lasting increase in c-Myc and also increased Bcl-x L (Fig. 7) . Fig. 7 emphasizes that the 1 and c-Myc protein, visible at 3.5 h and gone by 7 h, which was greater than the otherwise similar changes seen with levels of c-Myc and Egr-1 are below baseline by 7 h. They stay low at least to 16 h when they differ little from levels seen monoclonal anti-µ (Fig. 7) . Anti-CD40, which is apoptosis after cells enter apoptosis. However, in addition, a population of apoptotic cells binds high amounts of anti-B7-2 (not anti-B cells were incubated for 16 and 64 h with IL-4 at an optimal concentration, anti-CD40 at a suboptimal concentration or Hδ a /1 at I-A) regardless of the means of apoptosis induction. 0.5 µg/ml (which induced early apoptosis but no cell cycle entry in Fig. 2 ) and 10 µg/ml (which induced early apoptosis followed by cell cycle entry in Fig. 2 This study provides evidence that the direct interaction between B cells and anti-δ antibody may induce early (16 h) apoptosis at low concentration (0.1-1 µg/ml) or cycle entry at high concentration (10-100 µg/ml, Fig. 1 ). Apoptosis accelwith medium alone (not shown). There was no detectable change in c-Jun or c-Fos levels with low-dose anti-δ or antieration was much less evident with several anti-µ antibodies (Figs 3-5) than with anti-δ antibodies (Figs 1, 2 and 6 ). This µ (not shown).
B7-2 and class II MHC are up-regulated early in B cell difference was seen with both monoclonal and polyclonal anti-δ and anti-µ antibodies (Fig. 2) . Several explanations for activation (30) . The low concentration of Hδ a /1 anti-δ that induced apoptosis without cell cycle entry in Fig. 1 was able the difference in the apoptosis-inducing effects of anti-µ and anti-δ may be considered. The small dense B cell fraction to increase both B7-2 and class II MHC (Fig. 8A and B ). An equal concentration of B.7.6 anti-µ did not increase B7-2 or (called 'resting' because it shows baseline expression of several activation markers and no spontaneous progress out class II MHC (Fig. 8A and B) . Hδ a /1-treated B cells displaying high B7-2 and class II MHC appeared in both apoptotic of G 0 ) expresses much more IgD than IgM (9). For this reason alone, IgD cross-linking could generate more clustered Ig α (Annexin V ϩ ) and non-apoptotic populations. A small population of apoptotic cells (Annexin high ) bound more anti-B7-2 and β than surface IgM cross-linking. Furthermore, different antibodies bind to surface Ig with different affinities and than any of the live (Annexin low ) cells (Fig. 8D) . No similar geometries, which could affect their signaling properties. We considered how to adjust conditions so that anti-δ and anti-µ anti-δs to accelerate apoptosis (Fig. 2) . We concluded that on resting spleen B cells, low-level cross-linking of surface were delivering an 'equivalent signal', but none of the proximal signaling events was free of alternative interpretations. We IgD and IgM differ in their effects on apoptosis, whereas a higher level of cross-linking of either isotype induces similar decided on the strategy of using multiple mAb (three anti-δs and three anti-µs) over a 4-log concentration range to conentry into G 1 .
Cell cycle entry at 10-100 µg/ml anti-δ did not require vince ourselves that we were dealing with a consistent isotypebased difference. At no concentration did any of the three contaminating T cells because sort-purified B220 ϩ cells had a similar anti-δ dose response (data not shown). Monoclonal monoclonal anti-µs or the polyclonal anti-µ achieve the degree of apoptosis acceleration seen with any of the three monoand polyclonal anti-µ antibody at 10-100 µg/ml also stimulated cell cycle entry by 64 h. With 0.1-1 µg/ml B.7.6 and polyclonal clonal anti-δs or the polyclonal anti-δ (Figs 1-6 ). After 16 h exposure to 0.5-1 kg/ml of four different anti-δs, the increase anti-µ, there was a modest increase in apoptosis at 64 h (Fig. 3) which was not seen with 331 or DS-1 (Fig. 4) . However, in percent apoptotic cells ranged from 27 to 37%, whereas with four different anti-µs, the difference ranged from 9 to the striking early (16 h) increase seen with 0.1-1 µg/ml anti-δ was not observed with anti-µ, either as hypodiploid cells 15% (Figs 1-5) . The anti-δ believed to have the lowest crosslinking potential (11-26) required 10 times more than the other (Figs 3-5) or the plasma membrane transition detected with medium alone. With no further increase in apoptotic cells, between 16 and 64 h the increase in cycling cells was balanced by a decrease in G 0 cells (Fig. 1) . Thus, B cells responded to low concentrations of anti-δ with apoptosis and no cycle entry throughout their course, whereas at high concentrations cycle entry was associated with apoptosis protection (i.e. a rate of apoptosis lower than the spontaneous rate) even in the absence of 'signal 2'. B cells exposed to signal 1 in the form of 0.1-1 µg/ml anti-δ were rescued from early apoptosis by signal 2 in the form of anti-CD40 (even at the suboptimal level of 66 ng/ml) and IL-4, so that more cells survived to enter cycle by 64 h (Table 1) . In experiments not shown, 25 µg/ml anti-CD40 alone kept apoptosis levels at baseline in B cell cultures for at least 64 h. Cross-linking surface Ig to FcγRII on B cells has been shown to accelerate apoptosis, presumably contributing to per surface Ig molecule than mAb, especially at supersaturating concentrations like 25-100 µg/ml, one might expect to see an effect of Ig cluster size in this experiment. However, monoclonal anti-δ antibodies were at least as adept at indu-MC540 (see Results). In the animal, such a delay would give the anti-µ-treated B cell a greater opportunity to encounter cing apoptosis as polyclonal antibody (Fig. 2) , suggesting that linear aggregates of surface Ig were sufficient for the signal 2 and thereby escape death. Since 0.1 µg/ml anti-µ did not interfere with the apoptosis-inducing effect of apoptosis signal. Klaus et al. observed that when plastic plates were incubated with anti-µ or anti-δ, washed and B 0.1 µg/ml anti-δ, we concluded that in resting mature B cells anti-µ provides a much weaker signal for early apoptosis than cells were added, apoptosis was greater than when B cells were exposed directly to the same 50 µg/ml concentration of anti-δ, rather than blocking such a signal.
The modest apoptosis-accelerating effect of anti-µ B.7.6 antibody (28). They concluded that plate-bound antibody produced apoptosis because it effected a higher degree of (Fig. 3) and polyclonal anti-µ (Fig. 5) in BALB/c B cells was consistent with that reported by Kozono et al. (16) . In our cross-linking. Our dose-response data is consistent with theirs, but suggests that at least for anti-δ a different explanadata, 16 h of exposure to 0.5-1 µg/ml B.7.6 (Fig. 3) or polyclonal anti-µ (Fig. 5) increased the percent of apoptotic tion should be considered: that B cells on the plastic plate may be exposed to only~0.5% as much undenatured anti-δ cells from 36 to 48-50%. In the data of Kozono et al., 1 µg/ml polyclonal goat anti-µ increased the percent apoptotic as B cells incubated with soluble antibody (Fig. 6 ). There is evidence that much plate-bound antibody is inactivated, but cells from 41 to 56% at 18 h in BALB/c B cells. Other normal strains showed apoptosis percentages 12-19% greater in that elution of intact antibody is in the 1-2% range (J. E. Butler, pers. commun.). anti-µ than in medium at 18 h, whereas NZB B cells showed a smaller difference (~5%). Kozono et al. did not test anti-δ Another variable affecting how B cells respond to surface Ig engagement is the extent of cross-linking. Hasbold and antibodies (16), nor did they test DS-1 or 331, anti-µ antibodies that failed to accelerate apoptosis at any concentration in our Klaus have shown evidence that whereas both anti-δ and anti-µ at 50 µg/ml can activate (again consistent with Figs 1-hands (Fig. 4) .
B cells responding to 0.1-1 µg/ml anti-δ appeared to go 5), hyper-cross-linking of biotinylated anti-δ or anti-µ with avidin leads to apoptosis (27). Our data completes this picture into apoptosis directly from G 0 , similar to B cells in medium alone (Fig. 1) ; indeed without anti-CD40 or IL-4, these B cells by suggesting that degrees of cross-linking less than the optimum for activation can also induce apoptosis in mature continue to progress into apoptosis without much G 1 entry between 16 and 64 h. At 10-100 µg/ml, the 25:75% split B cells, but that in this low dose range, surface IgD transmits early apoptosis signals more readily than IgM. between apoptosis and G 0 at 16 h resembled that seen in
The concept that surface IgD may be more likely to send activation (15) , even as they are disappearing because of apoptosis. Similarly, many of the B cells exposed in vitro to an apoptosis signal than IgM is at variance with much of the previous literature. IgD expression is delayed until B cells are 0.2 µg/ml of anti-δ expressed elevated levels of B7-2 and Ia ( Fig. 8A and B) , even though they were not destined to attain mature enough to migrate to the periphery. Whereas mature B cells express IgD as well as IgM and respond to antigen G 1 (Fig. 1) . Indeed, some of the cells expressing these early signs of activation also expressed evidence of apoptosis in with activation, neonatal B cells lack surface IgD and respond to the same concentration of antigen with tolerance (2). These the form of increased Annexin V binding ( Fig. 8D and E) and loss of mitochondrial membrane potential (not shown), results suggested that engagement of surface IgD might block tolerance induction. The WEHI 231 cell line, with its characteristics of early apoptosis (26, 38) . Thus early activation and apoptosis events can occur in the same cells, when they immature M ϩ D -phenotype, has been extensively studied because anti-µ triggers apoptosis (33, 34) . When IgD heavy receive a modest BCR signal without a co-stimulatory signal. Seeking a molecular explanation for the difference in the and light chain-encoding vectors were transfected into WEHI 231 and expressed, anti-δ would still not cause apoptosis early apoptosis-promoting effect of low-dose anti-δ and anti-µ, we tested their effect on cellular oncogene and apoptosis (34) (35) (36) . These results suggested engagement of surface IgM alone might favor tolerance induction. These conclusions regulator expression. Although there is an association between increased c-Myc and increased apoptosis in were supported by experiments in which the sensitivity of spleen B cells to tolerance induction in vitro was increased fibroblasts (39), c-Myc and Egr-1 are generally associated with cell cycle progression in lymphocytes. Rapid loss of by prior removal of surface IgD (37) . Furthermore, in IgM anti-TNP transgenic mice, in vivo treatment with anti-µ or c-Myc is associated with apoptosis in WEHI-231 B cells (40-42) and also in normal spleen B cells (43, 44) , especially if multivalent TNP-antigens led to selective deletion of IgM bright cells in the spleen (11), resembling that seen in normal mice the fall is preceded by an abrupt rise (41, 42) . So it may be highly pertinent to apoptosis acceleration that low-dose antiwith anti-δ (15) . When surface IgD anti-TNP was co-expressed with IgM, deletion with antigen was much less effective.
δ induced a higher earlier rise in the level of oncogene products Egr-1 and c-Myc than either anti-µ preparation, Apoptosis was detected by DNA ladder in fresh IgM transgenic cells from mice treated with antigen 24 h before, but which accentuated the subsequent rapid drop to below baseline levels seen with both kinds of antibody (Fig. 7) . there was no comparison made to cells from IgM ϩ IgD transgenics (11). Thus it seems likely that conditions exist Alternatively, elevated c-Myc and Egr-1 might lead to apoptosis if other proteins that are only induced by high wherein IgM can also send an apoptosis-predominant signal in vivo or in vitro when engaged by plate-bound anti-µ (28), concentrations of anti-δ or anti-µ are absent, in which case the magnitude of the rise would be the deciding factor. We even though it was difficult to detect in vitro with soluble anti-µ antibody (Figs 4 and 5) .
observed no change in c-Jun (not shown) nor in Bcl-2, Bclx L or Bax with low-dose anti-δ or anti-µ (Fig. 7) . signal 1 (simulating ജ10 µg/ml in Figs 1-3 ) may be less dependent on signal 2 from T cells to be stimulated into has prevented T help, anti-IL-7 has prevented recruitment of new B cells from the marrow and 2.4G2 anti-FcγRII has cycle. In Table 1 , at 64 h, addition of IL-4, anti-CD40 or both to 10 µg/ml Hδ a /1 only raised the percent in cycle slightly, prevented B cell opsonization (15) . We reproduced these experimental conditions, and showed that on days 1, 3, 5 whereas they made a much greater difference with 0.5 µg/ml Hδ a /1. Further from the follicle center, where antigen and 10 after anti-δ administration, B220 ϩ spleen cells (but not B220 -cells) showed accelerated spontaneous apoptosis concentration is lower, the fate of the B cell hangs in the balance between cycle entry when signal 2 is available (45) rates in 16 h cultures, providing specific evidence that the anti-δ-induced disappearance of B cells was due to apoptosis and apoptosis when signal 2 is absent ( Fig. 1 and Table 1 ). In summary, this paper provides an especially clear illustra- (32) . If T help is present, anti-δ in vivo activates B cells instead (15) just as anti-CD40 and IL-4 rescued B cells in vitro from tion of the principle that a BCR signal without a co-stimulatory signal 2 leads to apoptosis. The anti-δ-induced disappearance anti-δ-induced apoptosis ( 
